BioCentury
ARTICLE | Company News

Andrx, Novartis Group deal

June 28, 1999 7:00 AM UTC

ADRX and Novartis' Geneva Pharmaceuticals Inc. subsidiary (Denver, Colo.) will develop certain controlled release dosage forms of existing products that ADRX is developing for NDA submission to the FD...